CARsgen Therapeutics, Ltd.   Report issue

For profit Phase 1 Phase 2
Founded: Shanghai China (2014)

Organization Overview

First Clinical Trial
2016
NCT02876978
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

CARsgen Pharmaceuticals Co.,Ltd | CARsgen Therapeutics Co., Ltd. | Carsgen Therapeutics, Ltd.